HEALTHCARE

Market Overview: Trocar is a surgical instrument that is used in various surgical procedures to insert implements into a blood vessel. The growing number of surgeries over the past few years is increasing the market size of trocars. Moreover, factors such as the increasing preferences for minimally invasive surgeries, the rising prevalence of chronic disorders that require surgery, and favorable reimbursement policies are escalating the market on the global platform. Market Research Future (MRFR) in its recently published study report asserts that the global Trocars Market Size will garner exponential accruals by 2023, registering 7.5% CAGR throughout the forecast period ( 2018-2023 ). The market had valued at USD 578.9 MN. in 2017. Additional factors having a synergistic effect on the growth of the Trocars market include the increasing number of technological advancements, a growing number of ambulatory services, and government initiatives. On the flip side, factors such...

Market Overview: Bleeding disorders result in susceptibility to bleeding due to faulty blood clotting, caused by defect in the blood coagulation. Bleeding disorders treatment includes the drugs used in the treatment and management of such bleeding disorders. The global bleeding disorders treatment market is continually growing owing to the prevalence of bleeding disorders such as hemophilia, platelet disorders, Von Willebrand disease and others. According to Market Research Future (MRFR), the global Bleeding Disorders Treatment Market Size is expected to garner a CAGR of over 10.0% over the assessment period (2018-2023). The demographic drivers of the market include the growing incidence of bleeding disorders and the growing population. According to the National Hemophilia Foundation hemophilia affects about 20,000 people in the United States and more than 400,000 people globally. Platelet disorders have an incidence of 1900to 6400 per 10000a year. Bleeding Disorders Treat...

Market Highlights: Rhabdomyosarcoma is anticipated to grow at a CAGR of 4.8%. Rhabdomyosarcoma or RMS is a type of soft tissue cancer. It is rare cancer and affects the skeletal muscle tissue. Sometimes, it also affects the hollow organs like uterus or bladder. RMS can affect people of any age, but it mostly affects children. The increasing prevalence of rhabdomyosarcoma, rising research & development expenditure and useful molecules in the pipeline are expected to drive the growth of the market during the forecast period. Additionally, the increasing awareness among people is likely to boost the market growth. On the other hand, high treatment costs, side effects of the treatment, improper results of the drugs in the pipeline and strict government regulations may hinder the growth of the market during the forecast period. The global Rhabdomyosarcoma Market is currently dominated by many market players. The key players in the market are engaging themselves in new product ...

Market Overview: Periodontal continues to be one of the major causes of tooth loss and a major oral health issue. The disease is common in both developed and developing countries, affecting nearly 20 to 50% of the global population. Over the years, different periodontal therapies have come up with a high degree of effectivity. Both surgical and non-surgical treatment options available. Global Periodontal Therapeutic Market Size is set to witness a strong growth in the forthcoming years. The latest study conducted by Market Research Future (MRFR) reveals that the global periodontal therapeutic market will surge at 9.2% CAGR during 2018 to 2023 .   The increasing demand for local antibiotic has resulted in a rise in research and development of local antibiotic. Owing to the increasing incidences of diabetic patients there is a rise in the periodontal therapeutic market. Whereas the rising prevalence of periodontal disorders and technological advancement in therapeutics ...